S&P 500   5,254.35
DOW   39,807.37
QQQ   444.01
Stock market today: Asian shares are mostly higher after another set of Wall St records
Delta Airline’s Put Option Activity Isn’t Bad News
3 Value Stocks Too Small For Buffett’s Portfolio
Disney Stock Catches 3 Upgrades In a Single Week
7 Stocks That Will Drive the Weight Loss Drugs Market
Walgreens Boots Alliance: Deep Value With Nowhere to Go But Up
Krispy Kreme's Sweet Deal: McDonald's Partnership Sparks Growth?
S&P 500   5,254.35
DOW   39,807.37
QQQ   444.01
Stock market today: Asian shares are mostly higher after another set of Wall St records
Delta Airline’s Put Option Activity Isn’t Bad News
3 Value Stocks Too Small For Buffett’s Portfolio
Disney Stock Catches 3 Upgrades In a Single Week
7 Stocks That Will Drive the Weight Loss Drugs Market
Walgreens Boots Alliance: Deep Value With Nowhere to Go But Up
Krispy Kreme's Sweet Deal: McDonald's Partnership Sparks Growth?
S&P 500   5,254.35
DOW   39,807.37
QQQ   444.01
Stock market today: Asian shares are mostly higher after another set of Wall St records
Delta Airline’s Put Option Activity Isn’t Bad News
3 Value Stocks Too Small For Buffett’s Portfolio
Disney Stock Catches 3 Upgrades In a Single Week
7 Stocks That Will Drive the Weight Loss Drugs Market
Walgreens Boots Alliance: Deep Value With Nowhere to Go But Up
Krispy Kreme's Sweet Deal: McDonald's Partnership Sparks Growth?
S&P 500   5,254.35
DOW   39,807.37
QQQ   444.01
Stock market today: Asian shares are mostly higher after another set of Wall St records
Delta Airline’s Put Option Activity Isn’t Bad News
3 Value Stocks Too Small For Buffett’s Portfolio
Disney Stock Catches 3 Upgrades In a Single Week
7 Stocks That Will Drive the Weight Loss Drugs Market
Walgreens Boots Alliance: Deep Value With Nowhere to Go But Up
Krispy Kreme's Sweet Deal: McDonald's Partnership Sparks Growth?
LON:HLN

Haleon (HLN) Share Price, News & Analysis

GBX 333.10
+3.10 (+0.94%)
(As of 03/28/2024 ET)
Today's Range
330.43
334.35
50-Day Range
312.05
333.10
52-Week Range
306.80
357.65
Volume
12.74 million shs
Average Volume
19.24 million shs
Market Capitalization
£30.41 billion
P/E Ratio
3,028.18
Dividend Yield
1.80%
Price Target
GBX 357.60

Haleon MarketRank™ Stock Analysis

Analyst Rating
Hold
2.00 Rating Score
Upside/​Downside
7.4% Upside
GBX 357.60 Price Target
Short Interest
N/A
Dividend Strength
Weak
Based on Four Factors
Sustainability
N/A
News Sentiment
0.30mentions of Haleon in the last 14 days
Based on 2 Articles This Week
Insider Trading
Selling Shares
£7.75 M Sold Last Quarter
Proj. Earnings Growth
N/A

Overall MarketRank

New Rank-Based ScoringMarketRank is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.

0.21 out of 5 stars

HLN stock logo

About Haleon Stock (LON:HLN)

Haleon plc, together with its subsidiaries, engages in the research, development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific. The company provides oral health, pain relief, respiratory health, digestive health, and other products, as well as vitamins, minerals, and supplements. Its portfolio of brands includes Advil, Sensodyne, Panadol, Voltaren, Theraflu, Otrivin, Polident, parodontax, and Centrum. The company was formerly known as DRVW 2022 plc and changed its name to Haleon plc in February 2022. Haleon plc was incorporated in 2021 and is headquartered in Weybridge, the United Kingdom.

HLN Stock Price History

HLN Stock News Headlines

Haleon (LON:HLN) Trading Down 1.2%
HLN Factor-Based Stock Analysis
SHOCKING Crypto Leak…
A shocking leak has revealed tech giant Microsoft's plans to add crypto support to future products. If the plans in these leaked internal documents pan out, we could see prices skyrocket for Bitcoin, Ethereum, XRP and MORE… The coupling of gaming and cryptocurrency could absolutely transform digital finance as we know it in 2024.
Prepare for Takeoff With Perrigo
Haleon PLC's Dividend Analysis
Haleon plc reports FY results
SHOCKING Crypto Leak…
A shocking leak has revealed tech giant Microsoft's plans to add crypto support to future products. If the plans in these leaked internal documents pan out, we could see prices skyrocket for Bitcoin, Ethereum, XRP and MORE… The coupling of gaming and cryptocurrency could absolutely transform digital finance as we know it in 2024.
Haleon Annual Pre-tax Profit, Revenue Improve
HLN Mar 2024 10.000 call
Here’s Why Cooper Investors Sold Haleon plc (HLN)
GSK raises £978m through Haleon share sale
See More Headlines
Receive HLN Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Haleon and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Ex-Dividend for 5/16 Dividend
3/14/2024
Today
3/28/2024
Dividend Payable
5/16/2024

Industry, Sector and Symbol

Sector
Medical
Industry
Drug Manufacturers - Specialty & Generic
Sub-Industry
N/A
CIK
N/A
Fax
N/A
Employees
24,622
Year Founded
N/A

Price Target and Rating

Average Stock Price Target
GBX 357.60
High Stock Price Target
GBX 391
Low Stock Price Target
GBX 280
Potential Upside/Downside
+7.3%
Consensus Rating
Hold
Rating Score (0-4)
2.00
Research Coverage
2 Analysts

Profitability

Net Income
£1.05 billion
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
£11.30 billion
Cash Flow
GBX 15.18 per share
Book Value
GBX 180 per share

Miscellaneous

Outstanding Shares
9,130,000,000
Free Float
N/A
Market Cap
£30.43 billion
Optionable
Not Optionable
Beta
N/A
The 10 Best AI Stocks to Own in 2024 Cover

Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.

Get This Free Report

Key Executives

  • Mr. Brian James McNamara (Age 58)
    CEO & Executive Director
    Comp: $2.35M
  • Mr. Tobias Hannes Hestler (Age 52)
    CFO & Executive Director
    Comp: $999k
  • Ms. Sonya Ghobrial (Age 50)
    Head of Investor Relations
  • Mr. Bjarne Philip Tellmann (Age 57)
    General Counsel
  • Ms. Tamara Rogers (Age 54)
    Chief Marketing Officer
  • Ms. Mairead Nayager (Age 49)
    Chief Human Resources Officer
  • Mr. Filippo Lanzi
    President of EMEA & LatAm
  • Mr. Keith Choy (Age 55)
    President of Asia Pacific
  • Ms. Lisa Paley (Age 57)
    President of North America
  • Mr. Franck Riot (Age 56)
    Chief R&D Officer

Should I Buy Haleon Stock? HLN Pros and Cons Explained

Pros

Here are some ways that investors could benefit from investing in Haleon plc:

  • Haleon plc has a strong market capitalization of £29.93 billion, indicating stability and potential growth.
  • The company recently increased its dividend payout, offering shareholders a yield of 1.34%, which can be attractive for income investors.
  • Analysts have set new price targets for Haleon, with a positive outlook, indicating potential stock price appreciation.
  • Haleon plc engages in the research, development, and sale of various consumer healthcare products globally, diversifying its revenue streams.
  • The company's portfolio of well-known brands, such as Advil, Sensodyne, and Panadol, provides a strong competitive advantage in the market.

Cons

Investors should be bearish about investing in Haleon plc for these reasons:

  • The company's debt-to-equity ratio is high at 57.66, which may pose risks in terms of financial leverage and solvency.
These pros and cons were generated based on recent news and financial data from MarketBeat in order to provide readers with the fastest and most accurate insights. They were last updated on Wednesday, March 27, 2024. Please send any questions or comments about these Haleon pros and cons to contact@marketbeat.com.

HLN Stock Analysis - Frequently Asked Questions

Should I buy or sell Haleon stock right now?

2 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Haleon in the last year. There are currently 1 sell rating and 1 buy rating for the stock. The consensus among Wall Street research analysts is that investors should "hold" HLN shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in HLN, but not buy additional shares or sell existing shares.
View HLN analyst ratings
or view top-rated stocks.

What is Haleon's stock price target for 2024?

2 Wall Street analysts have issued twelve-month price targets for Haleon's stock. Their HLN share price targets range from GBX 280 to GBX 391. On average, they expect the company's share price to reach GBX 357.60 in the next twelve months. This suggests a possible upside of 7.4% from the stock's current price.
View analysts price targets for HLN
or view top-rated stocks among Wall Street analysts.

How have HLN shares performed in 2024?

Haleon's stock was trading at GBX 321.65 at the beginning of the year. Since then, HLN shares have increased by 3.6% and is now trading at GBX 333.10.
View the best growth stocks for 2024 here
.

How often does Haleon pay dividends? What is the dividend yield for Haleon?

Haleon announced a dividend on Thursday, February 29th. Shareholders of record on Thursday, March 14th will be paid a dividend of GBX 4.20 per share on Thursday, May 16th. This represents a dividend yield of 1.34%. The ex-dividend date is Thursday, March 14th. This is a boost from the stock's previous dividend of GBX 1.80. The official announcement can be accessed at this link.
Read our dividend analysis for HLN
.

Is Haleon a good dividend stock?

Haleon (LON:HLN) pays an annual dividend of GBX 6 per share and currently has a dividend yield of 1.84%. The dividend payout ratio is 5,454.55%. Payout ratios above 75% are not desirable because they may not be sustainable.
Read our dividend analysis for HLN.

How do I buy shares of Haleon?

Shares of HLN stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.
Compare Top Brokerages Here.

This page (LON:HLN) was last updated on 3/29/2024 by MarketBeat.com Staff

From Our Partners